PL EN


Preferences help
enabled [disable] Abstract
Number of results
2003 | 63 | 2 | 101-108
Article title

FK506 attenuates 1-methyl-4-phenylpyridinium- and 3-nitropropionic acid-evoked inhibition of kynurenic acid synthesis in rat cortical slices

Selected contents from this journal
Title variants
Languages of publication
EN
Abstracts
EN
Kynurenic acid (KYNA), the only known endogenous glutamate antagonist, is produced in the brain by kynurenine aminotransferases (KATs) I and II. Mitochondrial toxins, 1-methyl-4-phenylpyridinium (MPP+) and 3-nitropropionic acid (3-NPA), were previously shown to reduce KYNA synthesis via interference with KAT I and II. Data presented here demonstrate that immunophilin ligand, FK506 (10-130 muM), but not CsA (1-50 muM), or ryanodine receptor blocker, dantrolene (1-100 muM), enhances the formation of KYNA in cortical slices. FK506, but not CsA or dantrolene, abolished the inhibition of KYNA synthesis evoked by MPP+ and 3-NPA. None of studied compounds influenced the activity of KAT I and KAT II. FK506 is the first among currently used drugs that might stimulate KYNA synthesis. This effect does not seem to arise from the interference with KATs or calcineurin activity.
Publisher

Year
Volume
63
Issue
2
Pages
101-108
Physical description
Contributors
author
author
author
author
author
References
Document Type
ARTICLE
Publication order reference
E. Luchowska, Department of Pharmacology and Toxicology, Medical University, Jaczewskiego 8, 20?090 Lublin, Poland
Identifiers
YADDA identifier
bwmeta1.element.element-from-psjc-ef917cea-040b-3194-9446-a84d46876e19
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.